Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives

International Journal of Cardiology

Volumn 54, Issue 2, 1996, Pages 157-163

  Caforio, Alida L P ^a,b   Goldman, Jonathan H ^a   Haven, Aldwyn J ^a   Baig, Kamran M ^a   McKenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Autoantibodies; Autoimmunity; Dilated cardiomyopathy; Familial; Immunology; Myosin

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DR4 ANTIGEN; MYOSIN;

AUTOIMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; HEART DILATATION; HUMAN; IMMUNOBLOTTING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029936350     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02593-4     Document Type: Article

References (51)

1. Brandeburg RO, Chazov E, Cherian G et al. Report of the WHO/ISFC task force on definition and classification of the cardiomyopathies. Circulation 1981; 64: 437A-438A.
2. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg AO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-531.
3. Kriett JM, Kaye MP. The Registry of the International Society for Heart Transplantation: seventh official report - 1990. J Heart Transplant 1990; 9: 323-330.
4. Mestroni L, Miani D, Di Lenarda A et al. Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol 1990; 65: 1449-1453.
5. Michels VV, Moll PP, Miller FA et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. New Engl J Med 1992; 326: 77-82.
6. Keeling PJ, Gang Y, Seo H et al. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 1995; 73: 417-421.
7. Zachara E, Caforio AL, Carboni GP et al. Familial aggregation of idiopathic dilated cardiomyopathy: clinical features and pedigree analysis in 14 families. Br Heart J 1993; 69: 129-135.
8. Caforio ALP. Role of autoimmunity in dilated cardiomyopathy. Br Heart J 1994; 72 (Suppl): S30-S34.
9. Woodruff J. Viral myocarditis - A review. Am J Pathol 1980; 101: 427-479.
10. Why HJ, Meany BT, Richardson PJ, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994; 89: 2582-2589.
11. Keeling PJ, Jeffery S, Caforio ALP, Taylor R, Bottazzo GF, McKenna WJ. Similar prevalence of enterovirus genome within the myocardium of patients with idiopathic dilated cardiomyopathy and controls shown by the polymerase chain reaction. Br Heart J 1992; 68: 554-559.
12. Giacca M, Severini GM, Mestroni L, et al. Low frequency of detection by nested PCR of enteroviral ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994; 24 (4): 1033-1040.
13. Keeling PJ, Lukaszyk A, Poloniecki J, et al. A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994; 23: 593-598.
14. Liljeqvist JA, Bergstrom T, Holmstrom S, et al. Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J Med Virol 1993; 39: 6-10.
15. Bottazzo GF, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R. Organ-specific autoimmunity. A 1986 overview. Immunol Rev 1986; 94: 137-169.
16. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1991; 14: 426-428.
17. Lernmark A. Molecular biology of IDDM. Diabetologia 1994; 37 (Suppl 2): S73-S81.
18. Neu N, Rose NR, Beisel KW, Herskovitz A, Gum-Glass G, Criag SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630-3636.
19. Smith SC, Allen PM. Myosin-induced myocarditis is a T cell-mediated disease. J Immunol 1991; 147: 2141-2147.
20. Aretz HT, Billingham ME, Edwards WE, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiol Pathol 1985; 1: 1-10.
21. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with viral myocarditis. Clin Exp Immunol 1983; 48: 533-545.
22. Schultheiss HP, Kuhl U, Schwimmbeck P, Strauer BE. Biomolecular changes in dilated cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF, editors. Advances in cardiomyopathies. Berlin: Springer, 1990; 221-234.
23. Wallukat G, Morwinski M, Kowal K, Forster A, Boewer V, Wollenberger A. Antibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J 1991; 12 (Suppl D): 178-181.
24. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994; 23: 146-153.
25. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16(4): 839-846.
26. Klein R, Maisch B, Kochsiek K, Berg PA. Demonstration of organ-specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984; 58: 283-292.
27. O'Connell J, Fowles RE, Robinson JA, Subramanian R, Henkin RE, Gunnar RM. Clinical and pathologic findings of myocarditis in two families with dilated cardiomyopathy. Am Heart J 1983; 107: 127-135.
28. Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation 1991; 83: 515-522.
29. Martinetti M, Dugoujon JM, Caforio ALP, et al. HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy. Hum Immunol 1992; 35: 193-199.
30. Caforio ALP, Stewart JT, Bonifacio E, et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun 1990; 3: 187-200.
31. Limas CJ, Goldenberg IF, Limas C. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation 1995; 91: 631-634.
32. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983; 52: 1071-1078.
33. Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, McKenna WJ. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15: 1527-1534.
34. Limas CJ, Limas C. β-Receptor antibodies and genetics in dilated cardiomyopathy. Eur Heart J 1991; 12 (Suppl D): 175-177.
35. Magnusson Y, Marullo S, Hoyer S, et al. Mapping of a functional autoimmune epitope on the β-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990; 86: 1658-1663.
36. Caforio ALP, Grazzini M, Mann JM. et al. Identification of a and β myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734-1742.
37. Fu LX, Magnusson Y, Bergh CH, et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91: 1964-1968.
38. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 1993; 22: 1378-1384.
39. Caforio ALP, Martinetti M, Bonifacio E, et al. Idiopathic dilated cardiomyopathy: lack of association between organ-specific cardiac antibodies and HLA-DR antigens. Tissue Antigens 1992; 39: 236-240.
40. Bilinska ZT, Caforio ALP, Grzybowski J, et al. Organ-specific cardiac autoantibodies in dilated cardiomyopathy: frequency and clinical correlates in Polish patients. Eur Heart J 1996 (in press).
41. Goldman JH, Warraich RS, Keeling PJ, et al. ELISA titers of anti-a myosin antibodies in idiopathic dilated cardiomyopathy patients reduce with disease progression. J Am Coll Cardiol 1995; (February, Special issue): 326 A.
42. Michels VV, Moll PP, Rodeheffer RJ, et al. Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy. Mayo Clin Proc 1994; 69: 24-27.
43. Caforio ALP, Keeling PJ, Zachara E, et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773-777.
44. Goldman JH, Keeling PJ, Warraich RS, et al. Autoimmunity to α-myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J 1995; 74: 598-603.
45. Neumann DA, Rose NR, Ansari AA, Herskowitz A. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J Immunol 1994; 152: 343-350.
46. Braciale TJ, Braciale VL. Antigen presentation: structural themes and functional variations. Immunol Today 1991; 12: 124-129.
47. Smith SC, Allen PM. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before the induction of autoimmune myocarditis. Proc Natl Acad Sci 1992; 89: 9131-9135.
48. Lodge PA, Herzum M, Huber SA. Coxsackie B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol 1987; 128: 455-463.
49. Schultheiss HP, Ulrich G, Janda I, Kuhl U, Morad M. Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 1988; 168: 2105-2119.
50. Eckstein R, Mempel W, Boite HD. Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation 1982; 6: 1224-1229.
51. Anderson JL, Carlquist JF, Hammond EH. Deficient natural killer cell activity in patients with dilated cardiomyopathy. Lancet 1982; II: 1124-1127.